Maximizing value of R&D Investment leveraging GenSight!
Sathiya Prabaharan | TrustRadius Reviewer
January 31, 2019

Maximizing value of R&D Investment leveraging GenSight!

Score 10 out of 10
Vetted Review
Verified User
Review Source

Overall Satisfaction with GenSight Enterprise Portfolio Management

At Integra Life Sciences, we leverage GenSight for R&D Portfolio Management, Project Management, Time Tracking and Resource Management. We have rolled out the system to ~350 users across Integra. We leverage GenSight to evaluate and prioritize the right opportunities, establish priority lists and conduct resource demand vs. supply analysis to appropriately staff priority projects. Time Tracking Data is also leveraged to obtain R&D Tax Credit. Financial models of all approved and proposed projects have been integrated into GenSight and we are leveraging the system to balance the portfolio, maximize value, ensure alignment to company strategy and balance between resources required and available.
  • Integrated system that combines Portfolio Management, Resource Management & Time Tracking
  • Risk and Value Analysis
  • R&D Tax Credit Report
  • Updates to Resource Requirements & Financial Model based on changes to Project Start and Launch Dates
  • Flexibility for Portfolio Admins to change attributes
  • Flexibility to run ad-hoc reports and integration to visualization tools
  • We have leveraged Time Tracking Data to maximize our R&D Tax Credit
  • We have been able to maximize the value of our Portfolio by enabling better visibility to programs across divisions and franchises
  • We have ensured that we are working on the right number of programs by ensuring a balance between cross-functional resources required and available.
  • Planview PPM Pro (formerly Innotas)
GenSight was better suited for Integra and was easier to implement.
GenSight Enterprise Portfolio Management is well suited for companies that want to implement top-down portfolio management capability to analyze risk vs. value, prioritize, optimize balance, maximize value and ensure strategic alignment of the global R&D portfolio. It may not be the best fit for companies that want to implement a bottom-up project management capability to track the status of programs and milestones.